| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2441 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2130 | 2020 |
| Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions Y Jamilloux, T Henry, A Belot, S Viel, M Fauter, T El Jammal, T Walzer, ... Autoimmunity reviews 19 (7), 102567, 2020 | 700 | 2020 |
| TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway S Viel, A Marçais, FSF Guimaraes, R Loftus, J Rabilloud, M Grau, ... Science signaling 9 (415), ra19-ra19, 2016 | 570 | 2016 |
| The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells A Marçais, J Cherfils-Vicini, C Viant, S Degouve, S Viel, A Fenis, ... Nature immunology 15 (8), 749-757, 2014 | 565 | 2014 |
| T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow C Daussy, F Faure, K Mayol, S Viel, G Gasteiger, E Charrier, J Bienvenu, ... Journal of Experimental Medicine 211 (3), 563-577, 2014 | 548 | 2014 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 438 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 327 | 2021 |
| In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper C Mayorga, G Celik, P Rouzaire, P Whitaker, P Bonadonna, ... Allergy 71 (8), 1103-1134, 2016 | 315 | 2016 |
| Type I IFN immunoprofiling in COVID-19 patients S Trouillet-Assant, S Viel, A Gaymard, S Pons, JC Richard, M Perret, ... Journal of Allergy and Clinical Immunology 146 (1), 206-208. e2, 2020 | 298 | 2020 |
| Regulation of mouse NK cell development and function by cytokines A Marçais, S Viel, M Grau, T Henry, J Marvel, T Walzer Frontiers in immunology 4, 72355, 2013 | 195 | 2013 |
| Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection MJ Van Helden, S Goossens, C Daussy, AL Mathieu, F Faure, A Marcais, ... Journal of experimental medicine 212 (12), 2015-2025, 2015 | 167 | 2015 |
| T‐bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1 J Zhang, M Marotel, S Fauteux‐Daniel, AL Mathieu, S Viel, A Marçais, ... European journal of immunology 48 (5), 738-750, 2018 | 150 | 2018 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 127 | 2022 |
| Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center P Sesques, E Ferrant, V Safar, F Wallet, J Tordo, A Dhomps, L Karlin, ... American journal of hematology 95 (11), 1324-1333, 2020 | 113 | 2020 |
| Alteration of natural killer cell phenotype and function in obese individuals S Viel, L Besson, E Charrier, A Marçais, E Disse, J Bienvenu, T Walzer, ... Clinical immunology 177, 12-17, 2017 | 104 | 2017 |
| PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator–dependent autoimmunity AL Mathieu, E Verronese, GI Rice, F Fouyssac, Y Bertrand, C Picard, ... Journal of Allergy and Clinical Immunology 135 (6), 1578-1588. e5, 2015 | 103 | 2015 |
| Monogenic lupus: dissecting heterogeneity O Omarjee, C Picard, C Frachette, M Moreews, F Rieux-Laucat, ... Autoimmunity Reviews 18 (10), 102361, 2019 | 97 | 2019 |
| High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors A Marçais, M Marotel, S Degouve, A Koenig, S Fauteux-Daniel, ... Elife 6, e26423, 2017 | 86 | 2017 |
| Early-onset autoimmunity associated with SOCS1 haploinsufficiency J Hadjadj, CN Castro, M Tusseau, MC Stolzenberg, F Mazerolles, ... Nature communications 11 (1), 5341, 2020 | 84 | 2020 |
